Santen 32-009

Status: Ongoing, but not recruiting participants

ClinicalTrials.gov Identifier: NCT02251938

Santen 32-009: A Phase IIIB, Multi-National, Multi-Center, Open-Label Extension Study Assessing the long-term Safety of the PRN Intravitreal Injections of DE-109 in subjects with Non-Infectious Uveitis of the Posterior Segment of the Eye who have participated in the SAKURA Development program.

Condition: Non-Infectious Uveitis of the Posterior Segment of the Eye

Study Type: Interventional

Duration: 12 months

Eligibility:

Ages: 18 years and older
Sexes: All
Accepts Healthy Volunteers: No

For additional information on this study, please click here

Back to Clinical Research